Annual Cash & Cash Equivalents
$51.99 M
-$134.61 M-72.14%
December 31, 2023
Summary
- As of February 8, 2025, VIGL annual cash & cash equivalents is $51.99 million, with the most recent change of -$134.61 million (-72.14%) on December 31, 2023.
- During the last 3 years, VIGL annual cash & cash equivalents has risen by +$27.84 million (+115.28%).
- VIGL annual cash & cash equivalents is now -72.14% below its all-time high of $186.60 million, reached on December 31, 2022.
Performance
VIGL Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$44.90 M
+$7.58 M+20.33%
September 30, 2024
Summary
- As of February 8, 2025, VIGL quarterly cash and cash equivalents is $44.90 million, with the most recent change of +$7.58 million (+20.33%) on September 30, 2024.
- Over the past year, VIGL quarterly cash and cash equivalents has dropped by -$11.90 million (-20.95%).
- VIGL quarterly cash and cash equivalents is now -77.98% below its all-time high of $203.86 million, reached on September 30, 2022.
Performance
VIGL Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
VIGL Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -72.1% | -20.9% |
| 3 y3 years | +115.3% | -20.9% |
| 5 y5 years | +115.3% | -20.9% |
VIGL Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -72.1% | at low | -78.0% | +20.3% |
| 5 y | 5-year | -72.1% | +115.3% | -78.0% | +20.3% |
| alltime | all time | -72.1% | +115.3% | -78.0% | +20.3% |
Vigil Neuroscience Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $44.90 M(+20.3%) |
| Jun 2024 | - | $37.31 M(-27.9%) |
| Mar 2024 | - | $51.76 M(-0.4%) |
| Dec 2023 | $51.99 M(-72.1%) | $51.99 M(-8.5%) |
| Sep 2023 | - | $56.79 M(-3.3%) |
| Jun 2023 | - | $58.74 M(-38.6%) |
| Mar 2023 | - | $95.62 M(-48.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $186.60 M(+104.1%) | $186.60 M(-8.5%) |
| Sep 2022 | - | $203.86 M(+36.9%) |
| Jun 2022 | - | $148.91 M(-8.8%) |
| Mar 2022 | - | $163.32 M(+78.7%) |
| Dec 2021 | $91.42 M(+278.5%) | $91.42 M(-17.4%) |
| Sep 2021 | - | $110.66 M |
| Dec 2020 | $24.15 M | - |
FAQ
- What is Vigil Neuroscience annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Vigil Neuroscience?
- What is Vigil Neuroscience annual cash & cash equivalents year-on-year change?
- What is Vigil Neuroscience quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Vigil Neuroscience?
- What is Vigil Neuroscience quarterly cash and cash equivalents year-on-year change?
What is Vigil Neuroscience annual cash & cash equivalents?
The current annual cash & cash equivalents of VIGL is $51.99 M
What is the all time high annual cash & cash equivalents for Vigil Neuroscience?
Vigil Neuroscience all-time high annual cash & cash equivalents is $186.60 M
What is Vigil Neuroscience annual cash & cash equivalents year-on-year change?
Over the past year, VIGL annual cash & cash equivalents has changed by -$134.61 M (-72.14%)
What is Vigil Neuroscience quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of VIGL is $44.90 M
What is the all time high quarterly cash and cash equivalents for Vigil Neuroscience?
Vigil Neuroscience all-time high quarterly cash and cash equivalents is $203.86 M
What is Vigil Neuroscience quarterly cash and cash equivalents year-on-year change?
Over the past year, VIGL quarterly cash and cash equivalents has changed by -$11.90 M (-20.95%)